LAUSR

eczema (73% of patients were also given concomitant topical antiscabetic treatment) and one case of diarrhoea and vomiting. Ivermectin was found to be effective in treating scabies in 85% of patients at the follow-up visit, with the remaining 15% of patients showing clinical signs of ongoing scabies. Currently oral ivermectin is available only in tablet formulation; however, no problems in administering the treatment to children were reported during the study. The current published medical literature suggests that oral ivermectin is safe to administer to children weighing < 15 kg. The recently published 2019 World Health Organization model list for essential medicines in children includes oral ivermectin. However, efficacy studies and optimum dosing regimens are still required to ensure that children are adequately treated with oral ivermectin for a number of diseases including scabies, and an oral liquid formulation to ease administration would be welcomed.